| Basics |
Ascendis Pharma A/S
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
|
| IPO Date: |
July 11, 2008 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$13.47B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.77 | 1.92%
|
| Avg Daily Range (30 D): |
$4.44 | 2.18%
|
| Avg Daily Range (90 D): |
$3.37 | 1.68%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.15M |
| Avg Daily Volume (30 D): |
.58M |
| Avg Daily Volume (90 D): |
.46M |
| Trade Size |
| Avg Trade Size (Sh.): |
66 |
| Avg Trade Size (Sh.) (30 D): |
51 |
| Avg Trade Size (Sh.) (90 D): |
48 |
| Institutional Trades |
| Total Inst.Trades: |
3,860 |
| Avg Inst. Trade: |
$3.57M |
| Avg Inst. Trade (30 D): |
$7.14M |
| Avg Inst. Trade (90 D): |
$6.25M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.42M |
| Avg Closing Trade (30 D): |
$8.51M |
| Avg Closing Trade (90 D): |
$6.8M |
| Avg Closing Volume: |
25.25K |
|
|
|
|
|
